The American Heart Association has expanded its education portfolio to help clinicians translate the first-ever cardiovascular-kidney-metabolic (CKM) syndrome guideline into practice. The new resources, announced via NEWMEDIAWIRE, range from 15-minute micro-learnings to in-depth courses and practical tools, with continuing education credit offerings varying by activity.
CKM syndrome describes the interconnectedness of cardiovascular, kidney, and metabolic conditions such as Type 2 diabetes and obesity. Since 2023, the American Heart Association has been a leader in advancing CKM health by convening experts across science, clinical care, and industry. The new education portfolio is designed to help healthcare professionals stay current with the latest evidence and apply recommendations in practice.
"CKM syndrome challenges clinicians to look beyond a single condition and consider how cardiovascular, kidney and metabolic health influence one another," said Ambar Kulshreshtha, M.D., Ph.D., a family practice physician and member of the Association's CKM Health Initiative. "These educational resources support a range of learning styles and busy schedules, giving care team members practical ways to build knowledge, stay current with the latest evidence and apply recommendations."
The Association's CKM education is hosted on the CKM Health for Professionals site, which is tailored for physicians, nurses, pharmacists, and other members of the healthcare team. Offerings include Micro-Learnings (15 minutes or less), short videos and activities that allow clinicians to refresh knowledge on topics such as measuring waist circumference or highlights from the 2026 CKM Syndrome Guideline. Podcasts, videos on demand, and apps and tools are also available.
Among the tools is a QuickStart guide for the American Heart Association Predicting Risk of cardiovascular disease EVENTsTM (PREVENT) Online Calculator, which estimates 10- and 30-year cardiovascular disease risk by integrating cardiovascular, kidney, and metabolic health measures. The Guidelines-on-the-Go app puts the latest science at clinicians' fingertips, and downloadable toolkits support day-to-day patient care.
Several educational experiences are offered by the American Heart Association's Cardiovascular-Kidney-Metabolic Health Initiative, supported by founding sponsors Novo Nordisk and Boehringer Ingelheim, supporting sponsors Novartis Pharmaceuticals Corporation and Bayer, and champion sponsor DaVita. The initiative aims to raise awareness of CKM syndrome, improve diagnosis rates, and help clinicians and patients better manage cardiovascular risk.
For patients and the public, this expansion means better-coordinated care as clinicians gain practical ways to apply the latest evidence. The initiative underscores the importance of addressing interconnected conditions together rather than in isolation. For more information, visit heart.org or stroke.org. The original release is available at www.newmediawire.com.
